NCT00134745View on ClinicalTrials.gov

Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Turner Syndrome
Interventions
DRUG

estradiol

tablets, 2 mg day 1 through day 22 of the menstrual cycle for 5 years

Trial Locations (1)

4300

Pediatric Unit, Hillerod Hospital, Hillerød

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

The County of Frederiksborg

UNKNOWN

collaborator

The foundation of Kaptajnløjtnant Harald Jensen and Wife

UNKNOWN

collaborator

The foundation of Mrs. Olga Bryde

UNKNOWN

collaborator

The foundation of Mr. Ivan Nielsen

UNKNOWN

lead

Line Cleemann

OTHER